Amalgamated Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

Amalgamated Financial’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$6.58M	Buy	+42,290	New	+$6.14M	0.05%	331

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Amalgamated Financial's JAZZ Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2022: 42,290 shares worth $6.58M. The stake represents 0.05% of the portfolio and ranks #331 among its holdings.

461 funds tracked by Wall St. Rank hold JAZZ as of Q1 2022.

Amalgamated Financial held 42,290 shares of Jazz Pharmaceuticals worth $6.58M as of Q1 2022.
Jazz Pharmaceuticals was a new Amalgamated Financial position in Q1 2022.
Jazz Pharmaceuticals made up 0.05% of Amalgamated Financial's portfolio in Q1 2022, its #331 holding.
461 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.